ENDRA Life Sciences (NDRA) Free Cash Flow: 2016-2021
Historic Free Cash Flow for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to -$2.7 million.
- ENDRA Life Sciences' Free Cash Flow fell 24.08% to -$2.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year decrease of 3.19%. This contributed to the annual value of -$7.4 million for FY2024, which is 22.60% up from last year.
- ENDRA Life Sciences' Free Cash Flow amounted to -$2.7 million in Q4 2021, which was up 3.42% from -$2.7 million recorded in Q3 2021.
- In the past 5 years, ENDRA Life Sciences' Free Cash Flow registered a high of -$236,274 during Q1 2017, and its lowest value of -$3.5 million during Q2 2020.
- Its 3-year average for Free Cash Flow is -$2.6 million, with a median of -$2.6 million in 2019.
- Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 937.73% in 2018, then rose by 18.90% in 2021.
- ENDRA Life Sciences' Free Cash Flow (Quarterly) stood at -$1.4 million in 2017, then plummeted by 38.30% to -$1.9 million in 2018, then fell by 2.28% to -$1.9 million in 2019, then declined by 9.87% to -$2.1 million in 2020, then decreased by 24.08% to -$2.7 million in 2021.
- Its Free Cash Flow stands at -$2.7 million for Q4 2021, versus -$2.7 million for Q3 2021 and -$2.8 million for Q2 2021.